APA (7th ed.) Citation

S, S., C, B., M, K., JM, M., U, O., K, S., . . . C, T. (2022). Deep sequencing in CD34+ cells from peripheral blood enables sensitive detection of measurable residual disease in AML. Blood advances, 6(11), 3294. https://doi.org/10.1182/bloodadvances.2021006233

Chicago Style (17th ed.) Citation

S, Stasik, et al. "Deep Sequencing in CD34+ Cells from Peripheral Blood Enables sensitive Detection of Measurable Residual Disease in AML." Blood Advances 6, no. 11 (2022): 3294. https://doi.org/10.1182/bloodadvances.2021006233.

MLA (9th ed.) Citation

S, Stasik, et al. "Deep Sequencing in CD34+ Cells from Peripheral Blood Enables sensitive Detection of Measurable Residual Disease in AML." Blood Advances, vol. 6, no. 11, 2022, p. 3294, https://doi.org/10.1182/bloodadvances.2021006233.